Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
5.40
-0.18 (-3.23%)
Jan 9, 2026, 12:52 PM EST - Market open
Biodesix Market Cap
Biodesix has a market cap or net worth of $42.96 million as of January 9, 2026. Its market cap has decreased by -81.19% in one year.
Market Cap
42.96M
Enterprise Value
102.18M
1-Year Change
-81.19%
Ranking
Category
Stock Price
$5.40
Market Cap Chart
Since October 28, 2020, Biodesix's market cap has decreased from $336.31M to $42.96M, a decrease of -87.23%. That is a compound annual growth rate of -32.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 44.39M | -17.94% |
| Dec 31, 2025 | 54.10M | -75.69% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 971.66B |
| Johnson & Johnson | 495.71B |
| AbbVie | 396.12B |
| UnitedHealth Group | 314.19B |
| AstraZeneca | 295.31B |
| Merck & Co. | 275.48B |
| Novartis AG | 273.11B |
| Novo Nordisk | 256.73B |